Nasdaq · Healthcare
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)
As-reported financials and recent SEC filings for NATURAL ALTERNATIVES INTERNATIONAL INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$129.9M
Net income
$-13.6M
Net margin
-10.5%
Diluted EPS
$-2.28
ROE
-19.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $129.9M | $113.8M | $154.0M | $171.0M | $178.5M |
| Gross profit | $9.3M | $6.9M | $18.2M | $30.5M | $30.4M |
| Operating income | $-8.7M | $-8.5M | $4.7M | $13.7M | $13.7M |
| Net income | $-13.6M | $-7.2M | $2.5M | $10.7M | $10.8M |
| Diluted EPS | $-2.28 | $-1.23 | $0.43 | $1.74 | $1.69 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
S-82026-05-21
View on EDGAR →10-Q2026-05-19
View on EDGAR →NT 10-Q2026-05-18
View on EDGAR →8-K2026-05-01
View on EDGAR →8-K2026-03-20
View on EDGAR →42026-03-10
View on EDGAR →42026-03-10
View on EDGAR →42026-03-10
View on EDGAR →Largest Healthcare peers
Go deeper on NAII
Search NATURAL ALTERNATIVES INTERNATIONAL INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.